Quality assurance

Clearsense Earns Validated Data Stream Designation from NCQA

Retrieved on: 
Mercoledì, Maggio 1, 2024
NCQA, Platform as a service, MD, Data, Quality assurance, Platform, National Committee

JACKSONVILLE, Fla., May 1, 2024 /PRNewswire/ -- Clearsense®, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it has earned the Validated Data Stream designation from the National Committee for Quality Assurance (NCQA) Data Aggregator Validation Program.

Key Points: 
  • Achievement ensures health plans, providers, and government entities can trust Clearsense as a source for accurate clinical data streams to use in HEDIS audits, quality reporting, and value-based care analytics
    JACKSONVILLE, Fla., May 1, 2024 /PRNewswire/ -- Clearsense ®, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it has earned the Validated Data Stream designation from the National Committee for Quality Assurance (NCQA) Data Aggregator Validation Program.
  • "Earning the NCQA's Validated Data Stream designation is not only a significant achievement for Clearsense; it's also a valuable asset for our customers," said Jason Z.
  • NCQA's Data Aggregator Validation program brings trust, comparability, and utility to clinical data streams for use in HEDIS and beyond," said Brad Ryan, MD, Chief Product Officer at NCQA.
  • For more information on NCQA Validated Data Stream designation, please click here .

126.3 m at 1.66% Li2O and 16.1 m at 5.02% Li2O in First Batch of 2024 Drill Results from CV5 at Corvette

Retrieved on: 
Mercoledì, Maggio 1, 2024
MRE, Lithium, The Company, TSX, Patriot, ASX, Quality assurance, CV5, Property, Atmosphere, Trans-Taiga Road, Val-d'Or, Growth, CV13, LCE

70.1 m at 2.44% Li2O, including 46.9 m at 3.53% Li2O or 16.1 m at 5.02% Li2O (CV24-401A).

Key Points: 
  • 70.1 m at 2.44% Li2O, including 46.9 m at 3.53% Li2O or 16.1 m at 5.02% Li2O (CV24-401A).
  • Core assay results are reported herein for 34 drill holes completed at CV5 in 2024.
  • Drill results for 34 drill holes, completed during the recently completed 2024 winter drill program at the CV5 Spodumene Pegmatite, are reported herein (Figure 1).
  • 70.1 m at 2.44% Li2O, including 46.9 m at 3.53% Li2O or 16.1 m at 5.02% Li2O (CV24-401A).

MITSUBISHI ELECTRIC AMERICA FOUNDATION ANNOUNCES $2 MILLION IN NEW GRANTS

Retrieved on: 
Martedì, Aprile 30, 2024
Vocational rehabilitation, Mechanics, Vocational education, Equity, Numerical control, CNC, Advanced manufacturing, Career, Disability, School, Commerce, Teaching, Autism spectrum, Quality assurance, Quality, Employment, Animation, Exceptional Minds, Mitsubishi Electric America Foundation, Plastic, Micro-enterprise, Electronics, Celebrate, FIRST, Acquisition, Student

WASHINGTON, April 30, 2024 /PRNewswire/ -- Mitsubishi Electric America Foundation (MEAF) announced today $2 million in new grants, and $615K in continuing projects. The funding supports MEAF's new Access to Careers in Technology and the Trades Inclusion Initiative, which is designed to empower youth with disabilities to lead productive lives through increased employment.

Key Points: 
  • WASHINGTON, April 30, 2024 /PRNewswire/ -- Mitsubishi Electric America Foundation (MEAF) announced today $2 million in new grants, and $615K in continuing projects.
  • Aspiritech Remote Employment Academy: To provide training and internships leading to careers in Accessibility, IT and Quality Assurance testing for neurodiverse individuals at Aspiritech .
  • FedCap's Teaching the Autism Community Trades (TACT) trains and places students as heat pump installers, electricians, welders, carpenters, and mechanics.
  • Access to careers in technology and the trades starts from a strong foundation of quality experiential education and awareness.

Affluent Medical : 2023 financial results and update on clinical activities under development.

Retrieved on: 
Venerdì, Maggio 3, 2024
Medtech, FDA, Risk, De novo, Death, Mitral regurgitation, Doctor of Philosophy, Wound healing, Mitral valve annuloplasty, Boston Scientific, Ticker, Wealth, Urinary incontinence, Woman, Christophe, Food, Neurostimulation, Myocardial infarction, Aix-en-Provence, DSM-IV codes, LCEA, Mitral valve, TAVI, Minerva, Certification, Heart, Quality assurance, System, Anatomy, Exercise, NYHA, Dry, Marketing, Clinical trial, American College, Development director, MD, Endocarditis, Medtronic, Patient, Tricuspid valve, Acquisition, Medical device

Affluent Medical : 2023 financial results and update on clinical activities under development.

Key Points: 
  • Affluent Medical : 2023 financial results and update on clinical activities under development.
  • Affluent Medical estimates that KaliosTM would avoid repeat surgery for 30-40% of patients within five years of their operation.
  • In September 2023, the Company presented interim data on 20 patients treated in five clinical centers in Europe after one year of implantation.
  • In July 2023, Affluent Medical announced the appointments of Christophe de Vregille as Chief Financial Officer and Benjamin Renault as Development Director.

Sharecare awarded three-year NCQA Accreditation for Case Management

Retrieved on: 
Mercoledì, Aprile 24, 2024
Health Promotion International, Case management, NCQA, Coronary artery disease, Sharecare, Health, Population health, Quality, Diabetes, Quality assurance, Environment, Accreditation, Patient, National Committee, Patient satisfaction, Asthma, Organization, Heart failure, Chronic obstructive pulmonary disease, Nursing

ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced it has received a three-year Case Management Accreditation by the National Committee for Quality Assurance (NCQA) for the complex case management capabilities available through its proprietary advocacy solution.

Key Points: 
  • ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced it has received a three-year Case Management Accreditation by the National Committee for Quality Assurance (NCQA) for the complex case management capabilities available through its proprietary advocacy solution.
  • “Further, combined with our existing three-year accreditations from NCQA for our population health and lifestyle and disease management programs, earning three-year accreditation for our approach to complex case management underscores Sharecare’s ability to build and deploy best-in-class solutions that make healthcare more personalized, accessible, and affordable for everyone.”
    NCQA Accreditation standards are developed with input from researchers in the field, the Case Management Expert Panel and standing committees, employers, both purchasers and operators of Case Management programs, state and federal regulators, and other experts.
  • “Case Management Accreditation moves us closer to measuring quality across population health management initiatives,” said Margaret E. O’Kane, President, NCQA.
  • Sharecare’s NCQA Case Management Accreditation is in addition to the three-year NCQA Population Health Program Accreditation it received in December 2021 for its platform, including programs for coronary artery disease, heart failure, asthma, diabetes, and chronic obstructive pulmonary disease; as well as the three-year NCQA Wellness and Health Promotion Accreditation awarded in August 2022 for Sharecare’s lifestyle and disease management interventions, which include the digital health company’s coaching programs and RealAge health risk assessment.

Huntington Bancshares Incorporated Hires Three Neurodiverse Teams Fulltime in Technology with CAI Neurodiverse Solutions

Retrieved on: 
Mercoledì, Aprile 17, 2024
HBAN, Information technology, Workplace, Quality assurance, CAI, Huntington Bancshares, Online shopping

ALLENTOWN, Pa., April 17, 2024 (GLOBE NEWSWIRE) -- CAI , a global technology services firm, today announced that Huntington Bancshares Incorporated (Nasdaq: HBAN) hired three teams of neurodivergent individuals fulltime after successfully contracting talent through CAI Neurodiverse Solutions, CAI’s end-to-end neurodiversity employment program.

Key Points: 
  • ALLENTOWN, Pa., April 17, 2024 (GLOBE NEWSWIRE) -- CAI , a global technology services firm, today announced that Huntington Bancshares Incorporated (Nasdaq: HBAN) hired three teams of neurodivergent individuals fulltime after successfully contracting talent through CAI Neurodiverse Solutions, CAI’s end-to-end neurodiversity employment program.
  • CAI Neurodiverse Solutions serves as Huntington’s talent incubator enhancing their internal workforce and offering long-lasting opportunities for the neurodiverse community.
  • Recognizing the benefits of neurodiversity in the workplace, Huntington has extended its engagement with CAI Neurodiverse Solutions by bringing on a fourth cohort of individuals.
  • To learn more about Huntington’s success with CAI Neurodiverse Solutions, visit https://www.cai.io/resources/success-stories/diversifying-employee-base-...
    To learn more about a Huntington associate’s story, visit https://www.cai.io/resources/success-stories/profiles/candidate-meet-mat...
    To learn more about CAI Neurodiverse Solutions, visit https://www.cai.io/neurodiverse-solutions/overview

Global Bioenergies ISO 9001 certified

Retrieved on: 
Martedì, Aprile 16, 2024
ISO 9001:2015, Marketing, SAF, Cosmetics, Global Bioenergies, Quality assurance, ISO, Certification

Evry, 16 April 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces its ISO 9001:2015 certification, the benchmark for quality worldwide.

Key Points: 
  • Evry, 16 April 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces its ISO 9001:2015 certification, the benchmark for quality worldwide.
  • Laurence Pruvost, Quality Assurance Manager at Global Bioenergies, comments: "We are proud to announce this certification.
  • It reflects the commitment of all our teams to implement a global approach that meets the requirements of our stakeholders, and in particular our customers.
  • This ISO 9001:2015 certification is part of a broader program of continuous improvement of the company's processes, aimed at operational excellence to support our industrial development."

Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally

Retrieved on: 
Giovedì, Maggio 2, 2024
Science, Biotechnology, Research, Pharmaceutical, Optical, General Health, Health, Clinical Trials, MD, Partnership, Quality assurance, SNEC, ChromeOS, Accreditation, Chandran, Eye, Toxicity, Associate, Ophthalmology

Ora, Inc. , the foremost global ophthalmology contract research organization (CRO), today announced a strategic, exclusive partnership with the Singapore Eye Research Institute (SERI), a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.

Key Points: 
  • Ora, Inc. , the foremost global ophthalmology contract research organization (CRO), today announced a strategic, exclusive partnership with the Singapore Eye Research Institute (SERI), a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.
  • This exclusive partnership marks a significant milestone in the ophthalmology research industry by combining the unparalleled clinical development expertise of Ora with the cutting-edge preclinical study capabilities of SERI.
  • Aimed at providing early-stage innovators around the world with comprehensive research support, this partnership is set to revolutionize the development of new ophthalmic therapies.
  • Ora and SERI both prioritize the assurance of data integrity, reinforcing the credibility and trustworthiness of the preclinical research conducted.

Papa Johns Announces Kurt Milburn as Chief Supply Chain Officer

Retrieved on: 
Giovedì, Maggio 2, 2024
Supply Chain Management, Retail, Food, Beverage, Supply, International, Papa John's, General Electric, Scotts Miracle-Gro Company, Quality assurance, Engineering, PZZA, General Motors, Senior, Organization, Knowledge, Management

Papa John's International, Inc. (NASDAQ: PZZA) today announced the promotion of Kurt Milburn to Chief Supply Chain Officer, succeeding Shane Hutchins, who will retire after 26 years at Papa Johns, where he served as Chief Supply Chain Officer since October 2018.

Key Points: 
  • Papa John's International, Inc. (NASDAQ: PZZA) today announced the promotion of Kurt Milburn to Chief Supply Chain Officer, succeeding Shane Hutchins, who will retire after 26 years at Papa Johns, where he served as Chief Supply Chain Officer since October 2018.
  • Mr. Milburn joined Papa Johns in 2022 as Vice President of Supply Chain Operations and since that time has taken on additional responsibility to include engineering and operations support functions as well as the International Supply Chain organization.
  • Prior to Papa Johns, Mr. Milburn served as Senior Vice President of Supply Chain Operations at Scotts Miracle-Gro Company.
  • “I’m thrilled for Kurt to become our next Chief Supply Chain Officer, as he brings deep expertise in supply chain and engineering from large, complex organizations and strong knowledge of our organization having led Papa Johns Food Service operations over the last two years.

Green Circle Life Expands Availability of Healthy Weight for Life Program for the SmartFHR™ Platform

Retrieved on: 
Martedì, Aprile 16, 2024
Technology, Professional Services, Health, Pharmaceutical, Health Technology, Health Insurance, Data Analytics, Software, Fitness & Nutrition, Human Resources, Telemedicine, Virtual Medicine, Snack, ROI, Pharmacy, NCQA, AutoZone, HR, Eli Lilly, Insurance, Compensation, Partnership, Weight loss, Doctor of Philosophy, Quality assurance, Pharmacotherapy, Prescription, Obesity, Exercise, Life, Novo Nordisk, Diet, GCL, Workforce, National Committee, Quality of life

HWFL is an employer-offered weight management program designed to work with individuals to set realistic goals, attain and maintain their desired weight through lifestyle changes.

Key Points: 
  • HWFL is an employer-offered weight management program designed to work with individuals to set realistic goals, attain and maintain their desired weight through lifestyle changes.
  • The program, which provides private, personalized coaching, encourages users to engage in physical activities, nutritional adjustments and monitor weight outcomes.
  • Dinesh Sheth, founder and CEO of Green Circle Life, emphasized, “Health and wellness are at the forefront of HR challenges, and obesity is a national epidemic.
  • Healthy weight is not a 'one and done' 'one size fits all' proposition but rather a constantly evolving journey.